✦ LIBER ✦

Auranofin and D-penicillamine: a one year comparative study of safety and efficacy in patients with rheumatoid arthritis followed by a two year open assessment of auranofin

✍ Scribed by Franchimont, P.; Hauwaert, C.; Vanschoubroek, K.

Book ID: 121544054
Publisher: Springer
Year: 1984
Tongue: English
Weight: 946 KB
Volume: 3
Category: Article
ISSN: 0770-3198
DOI: 10.1007/BF03342625

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Auranofin and gold sodium thiomalate in

Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: A one-year, double-blind, comparative multicenter study

✍ Schattenkirchner, M. ;Bröll, H. ;Kaik, B. ;Müller-Faßbender, H. ;Rau, R. ;Zeidle 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 857 KB

One-year experience in patients treated

One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo

✍ H. James Williams; Stephen L. Dahl; John R. Ward; Miki Karg; Robert F. Willkens; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

The efficacy and safety of leflunomide i

The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year followup study

✍ J. R. Kalden; M. Schattenkirchner; H. Sörensen; P. Emery; C. Deighton; B. Rozman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t

A 2-year comparative open label randomiz

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

✍ Anna Rita Giardina; Angelo Ferrante; Francesco Ciccia; Rosalia Impastato; Maria 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 239 KB

The incidence of the L.E. cell phenomeno

The incidence of the L.E. cell phenomenon in patients with rheumatoid arthritis. (A two-year study)

✍ John W. Sigler; Raymond W. Monto; Dwight C. Ensign; George M. Wilson Jr.; John W 📂 Article 📅 1958 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

Safety and Efficacy of the Selective Cos

Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study

✍ WESTHOVENS, R.; KREMER, J. M.; MORELAND, L. W.; EMERY, P.; RUSSELL, A. S.; LI, T 📂 Article 📅 2009 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 245 KB